Device Heart Valves

Avalus

Payments companies reported to CMS as associated with Avalus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$737Kassociated payments (2023-2025)
1,608clinicians with associated payments
1company reporting

By year

2023 $202K
2024 $259K
2025 $276K

Payments reported as associated with Avalus, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $510K
Surgery $119K
Anesthesiology $28K
Surgical $18K
Physician Assistant $12K
Cardiovascular Disease $7,730

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Avalus

These are the largest totals companies reported as associated with Avalus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Andy Kiser Pittsburgh, PA Surgery $110,829.69
Michael Moront Toledo, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $85,677.33
Gorav Ailawadi Ann Arbor, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $26,400.04
Bo Yang Ann Arbor, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $23,849.65
William Brinkman Plano, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $19,147.03
Douglas Johnston Chicago, IL Thoracic Surgery (Cardiothoracic Vascular Surgery) $18,978.36
Marc Pelletier New Haven, CT Thoracic Surgery (Cardiothoracic Vascular Surgery) $17,622.02
Pablo Ruda Vega Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $11,541.21
Michael Reardon Houston, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $11,349.62
Zhandong Zhou Syracuse, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $11,169.22

Prescribed Avalus?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.